Warning: The NCBI web site requires JavaScript to function. more...
A novel serum-free medium for the expansion of human mesenchymal stem cells.
Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC.
Stem Cell Res Ther. 2010 Apr 2;1(1):8.
Related citations
Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue.
Chieregato K, Castegnaro S, Madeo D, Astori G, Pegoraro M, Rodeghiero F.
Cytotherapy. 2011 Sep;13(8):933-43. Epub 2011 May 30.
Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
Bieback K, Hecker A, Kocaömer A, Lannert H, Schallmoser K, Strunk D, Klüter H.
Stem Cells. 2009 Sep;27(9):2331-41.
Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.
Reinisch A, Bartmann C, Rohde E, Schallmoser K, Bjelic-Radisic V, Lanzer G, Linkesch W, Strunk D.
Regen Med. 2007 Jul;2(4):371-82.
Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.
Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J, Zander AR.
J Cell Physiol. 2007 Oct;213(1):18-26.
Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components.
Fekete N, Gadelorge M, Fürst D, Maurer C, Dausend J, Fleury-Cappellesso S, Mailänder V, Lotfi R, Ignatius A, Sensebé L, Bourin P, Schrezenmeier H, Rojewski MT.
Cytotherapy. 2012 Feb 2. [Epub ahead of print]
Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
Pérez-Ilzarbe M, Díez-Campelo M, Aranda P, Tabera S, Lopez T, del Cañizo C, Merino J, Moreno C, Andreu EJ, Prósper F, Pérez-Simón JA.
Transfusion. 2009 Sep;49(9):1901-10. Epub 2009 May 20.
Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use.
Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR.
Exp Hematol. 2004 Dec;32(12):1212-25.
Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation.
Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, Abele H, Schewe B, Just L, Skutella T, Bühring HJ.
Differentiation. 2007 Apr;75(4):279-91. Epub 2006 Dec 11.
Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum.
Prins HJ, Rozemuller H, Vonk-Griffioen S, Verweij VG, Dhert WJ, Slaper-Cortenbach IC, Martens AC.
Tissue Eng Part A. 2009 Dec;15(12):3741-51.
Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, Umezawa A, Sekiya I.
Arthritis Rheum. 2008 Feb;58(2):501-10.
A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells.
Lennon DP, Haynesworth SE, Young RG, Dennis JE, Caplan AI.
Exp Cell Res. 1995 Jul;219(1):211-22.
Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T.
Biotechnol Bioeng. 2006 Apr 20;93(6):1152-63.
Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium.
Meuleman N, Tondreau T, Delforge A, Dejeneffe M, Massy M, Libertalis M, Bron D, Lagneaux L.
Eur J Haematol. 2006 Apr;76(4):309-16.
[In vitro expansion of the adult human bone marrow mesenchymal stem cells for clinic application in HSCT].
Kuang WY, Zhou XF, Zhang GS, Liu LH, Chen SF, Li RJ, Xiao L.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Jun;16(3):633-8. Chinese.
Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications.
Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JJ.
J Cell Physiol. 2005 Nov;205(2):228-36.
Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.
Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C, Obenauf AC, Lanzer G, Linkesch W, Strunk D.
Tissue Eng Part C Methods. 2008 Sep;14(3):185-96.
Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro.
Cassiede P, Dennis JE, Ma F, Caplan AI.
J Bone Miner Res. 1996 Sep;11(9):1264-73.
Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells.
Schallmoser K, Rohde E, Bartmann C, Obenauf AC, Reinisch A, Strunk D.
Biomed Mater Eng. 2009;19(4-5):271-6.
Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction.
Lodie TA, Blickarz CE, Devarakonda TJ, He C, Dash AB, Clarke J, Gleneck K, Shihabuddin L, Tubo R.
Tissue Eng. 2002 Oct;8(5):739-51.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on